Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine

Article Abstract:

The DTP and MMR vaccines may cause fever and a seizure in children a few days after vaccination, but this side effect will not last and does not produce long-term neurological disability. This was the conclusion of a study of 679,942 children vaccinated at four large HMOs.

Author: Davis, Robert L., DeStefano, Frank, Black, Steven B., Shinefield, Henry R., Chen, Robert T., Thompson, Robert S., Barlow, William E., Glasser, John W., Rhodes, Phillip H., Mullooly, John P., Ward, Joel I., Marcy, S. Michael
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2001
Causes of, Measles-mumps-rubella vaccine, Measles-mumps-rubella vaccines, Febrile convulsions, Febrile seizures, DPT vaccine, Diphtheria-tetanus-pertussis vaccines

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Efficacy of an acellular pertussis vaccine among adolescents and adults

Article Abstract:

A trial of an acellular pertussis vaccine among adolescents and adults evaluated the incidence of pertussis, vaccine safety, immunogenicity, and protective efficacy. Findings reveal that the accellular pertussis vaccine was protective among adolescents and adults, and its routine use might reduce the overall burden and transmission to children.

Author: Ward, Joel I., Cherry, James D., Bernstein, David I., Edwards, Kathryn, Greenberg, David P., Edelman, Robert, Treanor, John, Patridge, Susan, Keitel, Wendy, Barenkamp, Stephen, Swei-Ju Chang, Hang Lee
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2005
Youth, Health aspects, Children, Drug therapy, Teenagers, Child health, Whooping-cough, Whooping cough, Pertussis vaccines

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Safety of Revaccination With Pneumococcal Polysaccharide Vaccine

Article Abstract:

People who receive a second vaccination with pneumococcal polysaccharide vaccine (PPV) may be more likely to develop a minor reaction to the vaccine than those receiving it for the first time. PPV immunizes people against Streptococcus pneumoniae, which can cause serious infections. Researchers compared the rate of reactions at the injection site among 901 people who received their first PPV dose and 513 people who received a booster shot. Those receiving a booster shot were three times more likely to develop a reaction at the injection site. The reaction lasted an average of three days.

Author: Butler, Jay C., DeStefano, Frank, Lewis, Linda S., Chen, Robert T., Thompson, Robert S., Williams, Walter W., Jackson, Lisa A., Benson, Patti, Sneller, Vishnu-Priya, Holder, Patricia, Carlone, George, Lezhava, Tamar
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1999
Pneumococcal vaccine, Pneumococcal vaccines

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Complications and side effects, United States
Similar abstracts:
  • Abstracts: Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine
  • Abstracts: The utility of umbilical artery Doppler investigation in women with the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome
  • Abstracts: Differing mechanisms of inhibition of calcium increases in human uterine myocytes by indomethacin and nimesulide
  • Abstracts: Evidence that protease activated receptor 2 expression is enhanced in human coronary atherosclerotic lesions. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
  • Abstracts: Contemporary management of preterm premature rupture of membranes (PPROM): A survey of maternal-fetal medicine providers
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.